NCEL
NCEL
NASDAQ · Biotechnology

Newcelx Ltd

$2.43
+0.31 (+14.62%)
As of Apr 1, 4:20 PM ET ·
Financial Highlights (FY 2025)
Revenue
5.39M
Net Income
-1,299,864
Gross Margin
53.1%
Profit Margin
-24.1%
Rev Growth
-8.0%
D/E Ratio
0.74
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 53.1% 53.1% 53.1%
Operating Margin -24.5% -24.3% -27.1%
Profit Margin -24.1% -23.5% -17.7%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 5.39M 5.45M 4.30M
Gross Profit 2.86M 2.90M 2.28M
Operating Income -1,321,808 -1,323,832 -1,166,808
Net Income -1,299,864 -1,279,500 -760,803
Gross Margin 53.1% 53.1% 53.1%
Operating Margin -24.5% -24.3% -27.1%
Profit Margin -24.1% -23.5% -17.7%
Rev Growth -8.0% -5.0% +17.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 5.18M 4.90M 4.55M
Total Equity 7.04M 6.89M 6.84M
D/E Ratio 0.74 0.71 0.67
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,608,718 -1,854,994 -1,475,925
Free Cash Flow -1,268,218 -1,023,573 -724,682